Circulating vitamin D and risk of prostate cancer - Letter

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 1, 2012, Pages 246-

  Schwartz, Gary G ^a  

^a WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM;

CALCIUM INTAKE; CANCER RISK; CASE CONTROL STUDY; HUMAN; LETTER; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; VITAMIN BLOOD LEVEL;

HUMANS; MALE; PROSTATIC NEOPLASMS; VITAMIN D;

EID: 84855484012     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-0910     Document Type: Letter

References (5)

1. Albanes D, Mondul AM, Yu K, Pareisi D, Horst RL, Virtamo J, et al. Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study. Cancer Epidemiol Biomarkers Prev 2011;20:1850-60.
2. Rowland GW, Schwartz GG, John EM, Ingles SA. Calcium intake and prostate cancer among African Americans: effect modification by Vitamin D receptor calcium absorption genotype. J Bone Min Res. 2011 Sep 1. [Epub ahead of print].
3. Hirvonen T, Tapanainin H, Valsta L, Hannja M-L, Aro A, Pietenen P. Efficacy and safety of food fortification with calcium among adults in Finland. Pub Health Nutr 2006;9:792-97. (Pubitemid 46211754)
4. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PH, Clinton SK, et al. The 2011 report on Dietary Reference Intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011;96:53-8.
5. Schwartz GG. Sunlight, vitamin D and prostate cancer epidemiology. In: Feldman D, Pike JW, Adams JS, editors. Vitamin D. 3rd ed. Amsterdam, the Netherlands: Elsevier; 2011. p. 965-78.